{
    "clinical_study": {
        "@rank": "67144", 
        "arm_group": {
            "arm_group_label": "Breast cancer and Axillary Adenopathy", 
            "arm_group_type": "Other", 
            "description": "Women with breast cancer with abnormal appearing ipsilateral axillary nodes undergoing fine needle aspiration and core biopsy of a lymph node."
        }, 
        "brief_summary": {
            "textblock": "The study was performed to determine if either  ultrasound guided core biopsy or fine needle\n      aspiration of an axillary lymph node has superior sensitivity in detecting metastatic\n      carcinoma from the ipsilateral breast."
        }, 
        "brief_title": "Ultrasound Guided Core Biopsy vs Fine Needle Aspiration for Evaluation of Axillary Lymphadenopathy", 
        "completion_date": {
            "#text": "June 2011", 
            "@type": "Actual"
        }, 
        "condition": "Focus: Breast Cancer With Axillary Node Metastasis", 
        "condition_browse": {
            "mesh_term": [
                "Breast Neoplasms", 
                "Neoplasm Metastasis", 
                "Lymphatic Diseases"
            ]
        }, 
        "detailed_description": {
            "textblock": "Women with suspected or recently diagnosed breast cancer and ipsilateral abnormal appearing\n      axillary lymph nodes underwent fine needle aspiration immediately followed by core biopsy of\n      the same lymph node.Cytology results from the fine needle aspiration (FNA)and histology from\n      the core biopsy were compared to surgical pathology from axillary node excision to determine\n      if either method of percutaneous node sampling was more sensitive in detecting metastasis.\n      Pain during each procedure was also compared."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Women with breast cancer and abnormal ipsilateral axillary nodes visible on\n             sonography.\n\n        Exclusion Criteria:\n\n          -  Inability to understand consent form.\n\n          -  Emotionally unprepared to discuss possibility of axillary metastasis\n\n          -  Node not amenable to core biopsy"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "N/A"
        }, 
        "enrollment": {
            "#text": "105", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "August 1, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01920139", 
            "org_study_id": "PRO07100450"
        }, 
        "intervention": [
            {
                "arm_group_label": "Breast cancer and Axillary Adenopathy", 
                "description": "Ultrasound guided fine needle aspiration of an abnormal lymph node followed by ultrasound guided core biopsy of the same node followed by clip placement into the node.", 
                "intervention_name": "Fine needle aspiration and core biopsy of lymph node", 
                "intervention_type": "Procedure"
            }, 
            {
                "arm_group_label": "Breast cancer and Axillary Adenopathy", 
                "description": "Patients underwent axillary node dissection or excision of setinel axillary nodes at the time of surgical treatment of their breast cancer.", 
                "intervention_name": "Axillary surgery", 
                "intervention_type": "Procedure"
            }, 
            {
                "arm_group_label": "Breast cancer and Axillary Adenopathy", 
                "description": "A titanium marker was deposited into the lymph node that was percutaneously biopsied , immediately after the last tissue sample obtained.", 
                "intervention_name": "Titanium marker", 
                "intervention_type": "Other"
            }
        ], 
        "is_fda_regulated": "No", 
        "lastchanged_date": "August 6, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Pittsburgh", 
                    "country": "United States", 
                    "state": "Pennsylvania", 
                    "zip": "15213"
                }, 
                "name": "Magee Womens Hospital"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "1", 
        "official_title": "Ultrasound Guided Core Biopsy vs Fine Needle Aspiration for Evaluation of Axillary Lymphadenopathy in Patients Suspected of Having Breast Cancer.", 
        "other_outcome": {
            "description": "Patients were asked to report pain level during the 2 types of percutaneous biopsy.", 
            "measure": "Pain associated with each type of percutaneous biopsy procedure", 
            "safety_issue": "No", 
            "time_frame": "immediate at time of biopsy"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: University of Pittsburgh Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "June 2011", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "Results of FNA cytology and core biopsy histology are compared to axillary surgery results.", 
            "measure": "Fraction of metastatic nodes found at axillary surgery that were identified pre-surgically by FNA vs. core biopsy", 
            "safety_issue": "No", 
            "time_frame": "1 week to 10 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01920139"
        }, 
        "responsible_party": {
            "investigator_affiliation": "University of Pittsburgh", 
            "investigator_full_name": "Marie Ganott", 
            "investigator_title": "MD", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "University of Pittsburgh", 
        "sponsors": {
            "collaborator": [
                {
                    "agency": "Magee Womens Hospital foundation", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Suros Surgical (now Hologic )", 
                    "agency_class": "Other"
                }
            ], 
            "lead_sponsor": {
                "agency": "University of Pittsburgh", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "December 2008", 
        "study_design": "Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic", 
        "study_type": "Interventional", 
        "verification_date": "August 2013"
    }
}